April 2024
1. HU HH, Wang SQ, Zhao H, Chen ZS, et al
   HER2(+) advanced gastric cancer: Current state and opportunities (Review).
   Int J Oncol. 2024;64:36.
   

   >> Share

   
   
2. XU J, Yu B, Wang F, Yang J, et al
   Xenograft and organoid models in developing precision medicine for gastric cancer (Review).
   Int J Oncol. 2024;64:41.
   

   >> Share

   
   March 2024
3. WANG M, Shu H, Cheng X, Xiao H, et al
   Exosome as a crucial communicator between tumor microenvironment and gastric cancer (Review).
   Int J Oncol. 2024;64:28.
   

   >> Share

   
   
4. CHONG Y, Yu D, Lu Z, Nie F, et al
   Role and research progress of spasmolytic polypeptide?expressing metaplasia in gastric cancer (Review).
   Int J Oncol. 2024;64:33.
   

   >> Share

   
   August 2023
5. ZHENG X, Shao J, Qian J, Liu S, et al
   circRPS19 affects HK2‑mediated aerobic glycolysis and cell viability via the miR‑125a‑5p/USP7 pathway in gastric cancer.
   Int J Oncol. 2023;63:98.
   

   >> Share

   
   July 2023
6. SONG Y, Guo D, Liu JF, Ge LN, et al
   Downregulation of miR‑7 and miR‑153 is involved in Helicobacter pylori CagA induced gastric carcinogenesis and progression.
   Int J Oncol. 2023;63:79.
   

   >> Share

   
   June 2023
7. WANG J, Hu W, Wu X, Wang K, et al
   [Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation.
   Int J Oncol. 2023;62:72.
   

   >> Share

   
   November 2022
8. ZHANG Q, Ali M, Wang Y, Sun QN, et al
   Galectin1 binds GRP78 to promote the proliferation and metastasis of gastric cancer.
   Int J Oncol. 2022;61.
   

   >> Share

   
   July 2022
9. HAM IH, Wang L, Lee D, Woo J, et al
   Curcumin inhibits the cancerassociated fibroblastderived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway.
   Int J Oncol. 2022;61.
   

   >> Share

   
   June 2022
10. SAKATA K, Kanda M, Shimizu D, Nakamura S, et al
    Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer.
    Int J Oncol. 2022;60.
    

    >> Share

    
    May 2022
11. ZHU H, Jiang W, Zhu H, Hu J, et al
    Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer.
    Int J Oncol. 2022;60.
    

    >> Share

    
    March 2022
12. ZHU X, Liu J, Xu X, Zhang C, et al
    [Corrigendum] The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance.
    Int J Oncol. 2022;60.
    

    >> Share

    
    December 2021
13. ITO K, Kitajima Y, Kai K, Matsufuji S, et al
    Matrix metalloproteinase1 expression is regulated by HIF1dependent and epigenetic mechanisms and serves a tumorsuppressive role in gastric cancer progression.
    Int J Oncol. 2021;59.
    

    >> Share

    
    April 2021
14. OUYANG J, Xie Z, Lei X, Tang G, et al
    Clinical crosstalk between microRNAs and gastric cancer (Review).
    Int J Oncol. 2021;58:1.
    

    >> Share

    
    January 2021
15. BALI P, Lozano-Pope I, Pachow C, Obonyo M, et al
    Early detection of tumor cells in bone marrow and peripheral blood in a fastprogressing gastric cancer model.
    Int J Oncol. 2021 Jan 12. doi: 10.3892/ijo.2021.5171.
    

    >> Share

    
    September 2020
16. FENG J, Xiao T, Lu SS, Hung XP, et al
    ANXA1derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation.
    Int J Oncol. 2020 Sep 7. doi: 10.3892/ijo.2020.5119.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share